DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
19.90
+0.32 (1.63%)
Jan 22, 2026, 3:00 PM CST
DaShenLin Pharmaceutical Group Company Description
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, distributes, and retails pharmaceutical products in China.
It offers Chinese and Western patent medicines, ginseng and antler tonic medicinal materials, Chinese herbal medicine slices, health products, medical devices, and other commodities.
The company was incorporated in 1999 and is based in Guangzhou, China.
DaShenLin Pharmaceutical Group Co., Ltd.
| Country | China |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 43,532 |
| CEO | Guoqiang Ke |
Contact Details
Address: No. 410-1, Longxi Avenue Guangzhou, 51000 China | |
| Phone | 86 20 8168 9688 |
| Website | dslyy.com |
Stock Details
| Ticker Symbol | 603233 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002RG2 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Guoqiang Ke | GM and Director |
| Guangzhi Peng | Financial Director and Secretary to the Board |
| Qun Fei Tan | Deputy GM and Director |
| Hong Chen | Deputy General Manager |
| Xin Jiang | Deputy General Manager |
| Changcheng Chen | Deputy General Manager |
| Zhi Hui Chen | Chairman of Supervisory Board and Deputy Director of Human Resources Department - Guangdong Province |
| Tuo Ji Ke | Deputy General Manager |